Last reviewed · How we verify

NCT05844475: FGGvsBSG+CM

Buccal Graft + Collagen Matrix Versus Free Gingival Graft for Keratinized Mucosa Augmentation at Implant Sites

Active, enrolled NA Last updated 10 April 2025
What this trial tests

NA trial testing Conventional Free Gingival Graft Approach (FGG) in Surgery in 32 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline
13 April 2023
Primary endpoint
21 September 2025
21 December 2025

Quick facts

Lead sponsorHarvard Medical School (HMS and HSDM)
PhaseNA
StatusActive, enrolled
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment32
Start date13 April 2023
Primary completion21 September 2025
Estimated completion21 December 2025
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Harvard Medical School (HMS and HSDM)

Who can join

18 and older, any sex, with Surgery. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study aims at comparing two different approaches for soft tissue augmentation at implants lacking keratinized and adherent mucosa width: the free gingival graft (FGG) vs the Buccal Strip Graft in combination with a xenogeneic collagen matrix (BSG + CM)

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Surgery

Currently open trials in the same condition.

Other Harvard Medical School (HMS and HSDM) trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05844475.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing